VORAPAXAR SULFATE
| Brand name | ZONTIVITY |
|---|---|
| Active ingredient | VORAPAXAR SULFATE |
| Strength | EQ 2.08MG BASE |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | May 2014 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 7304078 | December 2027 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.